<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="sciences : Microbiology : Medical microbiology : Microbial pathogens :" exact="Viral" post="pathogens : Coronaviruses : SARS coronavirus: SARS CoV 2"/>
 <result pre="Pathology and laboratory medicine : Pathogens : Microbial pathogens :" exact="Viral" post="pathogens : Coronaviruses : SARS coronavirus: SARS CoV 2"/>
 <result pre=": Biology and life sciences : Organisms : Viruses :" exact="Viral" post="pathogens : Coronaviruses : SARS coronavirus: SARS CoV 2"/>
 <result pre="2 : Medicine and Health Sciences : Medical Conditions :" exact="Infectious" post="Diseases : Infectious Disease Control: Social Distancing : Medicine"/>
 <result pre=": Medicine and Health Sciences : Medical Conditions : Infectious" exact="Diseases" post=": Infectious Disease Control: Social Distancing : Medicine and"/>
 <result pre="and Health Sciences : Medical Conditions : Infectious Diseases :" exact="Infectious" post="Disease Control: Social Distancing : Medicine and Health Sciences"/>
 <result pre="Health Sciences : Medical Conditions : Infectious Diseases : Infectious" exact="Disease" post="Control: Social Distancing : Medicine and Health Sciences :"/>
 <result pre="Distancing : Medicine and Health Sciences : Medical Conditions :" exact="Infectious" post="Diseases: Respiratory Infections : Medicine and Health Sciences :"/>
 <result pre="Medicine and Health Sciences : Medical Conditions : Infectious Diseases:" exact="Respiratory" post="Infections : Medicine and Health Sciences : Medical Conditions"/>
 <result pre="and Health Sciences : Medical Conditions : Infectious Diseases: Respiratory" exact="Infections" post=": Medicine and Health Sciences : Medical Conditions :"/>
 <result pre="Infections : Medicine and Health Sciences : Medical Conditions :" exact="Respiratory" post="Disorders: Respiratory Infections : Medicine and Health Sciences :"/>
 <result pre="Medicine and Health Sciences : Medical Conditions : Respiratory Disorders:" exact="Respiratory" post="Infections : Medicine and Health Sciences : Pulmonology :"/>
 <result pre="and Health Sciences : Medical Conditions : Respiratory Disorders: Respiratory" exact="Infections" post=": Medicine and Health Sciences : Pulmonology : Respiratory"/>
 <result pre="Respiratory Infections : Medicine and Health Sciences : Pulmonology :" exact="Respiratory" post="Disorders: Respiratory Infections : People and places : Geographical"/>
 <result pre=": Medicine and Health Sciences : Pulmonology : Respiratory Disorders:" exact="Respiratory" post="Infections : People and places : Geographical locations :"/>
 <result pre="Medicine and Health Sciences : Pulmonology : Respiratory Disorders: Respiratory" exact="Infections" post=": People and places : Geographical locations : North"/>
 <result pre=": Epidemiology: Social Epidemiology Modeling the role of asymptomatics in" exact="infection" post="spread with application to SARS-CoV-2 Asymptomatics in SARS-CoV-2 http://orcid.org/0000-0003-3592-6770DobrovolnyHana"/>
 <result pre="original author and source are credited.pone.0236976.pdf Abstract SARS-CoV-2 started causing" exact="infections" post="in humans in late 2019 and has spread rapidly"/>
 <result pre="this study, we use a compartmental mathematical model of a" exact="viral" post="epidemic that includes asymptomatic infection to examine the role"/>
 <result pre="compartmental mathematical model of a viral epidemic that includes asymptomatic" exact="infection" post="to examine the role of asymptomatic individuals in the"/>
 <result pre="in California, Florida, New York, and Texas, finding that asymptomatic" exact="infections" post="far outnumber reported symptomatic infections at the peak of"/>
 <result pre="York, and Texas, finding that asymptomatic infections far outnumber reported" exact="symptomatic" post="infections at the peak of the epidemic in all"/>
 <result pre="and Texas, finding that asymptomatic infections far outnumber reported symptomatic" exact="infections" post="at the peak of the epidemic in all four"/>
 <result pre="widely around the world. The virus can cause a severe" exact="respiratory" post="illness, known as COVID-19, characterized by fever and cough"/>
 <result pre="COVID-19, characterized by fever and cough that can lead to" exact="respiratory" post="failure and death [3, 4]. The virus appears to"/>
 <result pre="cases. One study estimated that the asymptomatic proportion of SARS-CoV-2" exact="infections" post="on the Diamond Princess cruise ship docked outside Tokyo"/>
 <result pre="Japanese evacuees from Wuhan, China estimated the proportion of asymptomatic" exact="infections" post="at ∼30% [11]. A similar study of German nationals"/>
 <result pre="that ∼5% of patients testing positive for SARS-CoV-2 had asymptomatic" exact="infections" post="[15]. While the exact proportion of asymptomatic infections is"/>
 <result pre="had asymptomatic infections [15]. While the exact proportion of asymptomatic" exact="infections" post="is still unclear, these studies indicate that asymptomatic infections"/>
 <result pre="asymptomatic infections is still unclear, these studies indicate that asymptomatic" exact="infections" post="with SARS-CoV-2 are not uncommon. However, it is not"/>
 <result pre="are not uncommon. However, it is not enough that asymptomatic" exact="infections" post="exist. In order for asymptomatic individuals to spread the"/>
 <result pre="indicate this might in fact be the case for asymptomatic" exact="infections" post="with SARS-CoV-2. Zhang et al. [16] report on a"/>
 <result pre="infections with SARS-CoV-2. Zhang et al. [16] report on a" exact="familial" post="cluster of COVID patients initiated by an asymptomatic individual."/>
 <result pre="other members of his family [17]. A series of SARS-CoV-2" exact="infections" post="among business associates in Germany was traced to a"/>
 <result pre="study of transmission in China that suggests that ∼86% of" exact="infections" post="were caused by asymptomatic or unreported cases [9]. These"/>
 <result pre="asymptomatics during an epidemic have previously been done for other" exact="infectious diseases" post="[19–26]. These models have estimated the proportion of asymptomatic"/>
 <result pre="the current SARS-CoV-2 pandemic, isolation and social distancing are the" exact="primary" post="weapons in stopping the spread of the infection. In"/>
 <result pre="paper, we study a compartmental epidemic model that includes asymptomatic" exact="infections" post="to determine the role that asymptomatic individuals might play"/>
 <result pre="New York, and Texas, finding that a large number of" exact="infections" post="in these states are unreported and that relaxing social"/>
 <result pre="distancing measures too early will cause a rapid spike in" exact="infections" post="driven in part by these hidden infections. Materials and"/>
 <result pre="Mathematical model We use a compartmental model that includes asymptomatic" exact="infections" post="with assumptions geared towards modeling the current SARS-CoV-2 pandemic,"/>
 <result pre="died. We assume that the course of the epidemic is" exact="short" post="compared to the human lifespan and do not include"/>
 <result pre="births or deaths from other causes, instead assuming that the" exact="total" post="population, N = S + A + I +"/>
 <result pre="the asymptomatics can infect susceptible individuals, but with a different" exact="infection" post="rate, determined by the proportionality constant r. We assume"/>
 <result pre="File. We assume that the epidemic starts with a single" exact="symptomatic" post="individual, I(0) = 1 and that there are no"/>
 <result pre="time of the infection. We fix the death rate of" exact="symptomatic" post="individuals to δ = 0.056/d based on mean time"/>
 <result pre="cumulative infected individuals. Early in the pandemic, testing was primarily" exact="limited" post="to individuals who displayed symptoms, so the case count"/>
 <result pre="case count in this data set should primarily consist of" exact="symptomatic" post="individuals. We simultaneously fit both the infected and dead"/>
 <result pre="through bootstrapping with 1000 replicates. Results Effect of asymptomatics on" exact="infection" post="size and deaths We explored the effect of asymptomatics"/>
 <result pre="explored the effect of asymptomatics on the course of the" exact="infection" post="using a base set of parameters given in Table"/>
 <result pre="and used estimates for the remaining parameters from the literature." exact="Infections" post="are initiated with a single symptomatic infected individual. The"/>
 <result pre="parameters from the literature. Infections are initiated with a single" exact="symptomatic" post="infected individual. The infection rate was taken from a"/>
 <result pre="Infections are initiated with a single symptomatic infected individual. The" exact="infection" post="rate was taken from a model fit to data"/>
 <result pre="was taken from a model fit to data of coronavirus" exact="infections" post="from China [9]; they estimate infection rates before and"/>
 <result pre="to data of coronavirus infections from China [9]; they estimate" exact="infection" post="rates before and after travel bans and social distancing"/>
 <result pre="is defined as the number of dead divided by the" exact="total" post="number infected. The size of the epidemic is measured"/>
 <result pre="the epidemic is measured here as the proportion of the" exact="total" post="population who become infected, either symptomatically or asymptomatically. Results"/>
 <result pre="1 for both high (left column) and low (right column)" exact="infection" post="rates. We see that the relative infectivity (r) of"/>
 <result pre="of r except when p is near one. In the" exact="upper" post="left corner, there is a pocket where the mortality"/>
 <result pre="the mortality is zero; this is particularly evident for the" exact="lower" post="infection rate. This pocket is more clearly defined for"/>
 <result pre="mortality is zero; this is particularly evident for the lower" exact="infection" post="rate. This pocket is more clearly defined for the"/>
 <result pre="time of peak are fairly constant until we approach the" exact="upper" post="left hand corner where there is a rapid decrease"/>
 <result pre="p ) β α + δ represents spread due to" exact="symptomatic" post="individuals. Fig 1 Effect of asymptomatic individuals on case-fatality"/>
 <result pre="(bottom row). The left column shows results for a high" exact="infection" post="rate and the right column shows results for a"/>
 <result pre="rate and the right column shows results for a low" exact="infection" post="rate. The relative infectivity of asymptomatics (r) has little"/>
 <result pre="interesting to understand the trade-off between the proportion of asymptomatic" exact="infections" post="and the relative infectivity in contributing to a particular"/>
 <result pre="(Fig 2 (left)) and low (Fig 2 (right)) values of" exact="infection" post="rate. Solving for p in the R0 equation gives"/>
 <result pre="+ δ ) - k β . (3) When the" exact="infection" post="rate is high, a high proportion of asymptomatics and"/>
 <result pre="higher values of r for a particular R0. When the" exact="infection" post="rate is low, we see a slightly different relationship"/>
 <result pre="for high R0—when R0 = 3, increasing r values require" exact="lower" post="values of p for a particular R0. This change"/>
 <result pre="to achieve a particular basic reproduction number for a high" exact="infection" post="rate (left) and low infection rate (right). In the"/>
 <result pre="reproduction number for a high infection rate (left) and low" exact="infection" post="rate (right). In the current COVID pandemic, public health"/>
 <result pre="current COVID pandemic, public health authorities have been attempting to" exact="lower" post="the infection rate through social distancing measures, so we"/>
 <result pre="pandemic, public health authorities have been attempting to lower the" exact="infection" post="rate through social distancing measures, so we more closely"/>
 <result pre="more closely examined the dependence of the epidemic threshold on" exact="infection" post="rate. Fig 3 shows the R0 = 1 (the"/>
 <result pre="1 (the epidemic threshold value) curves for different values of" exact="infection" post="rate (β). R0 &amp;lt; 1 is to the left"/>
 <result pre="the left of each curve. We see that as the" exact="infection" post="rate is lowered, there are more combinations of r"/>
 <result pre="p that result in no epidemic. That is, the general" exact="infection" post="rate is just not high enough to support spread"/>
 <result pre="is just not high enough to support spread of the" exact="infection" post="no matter what the proportion of asymptomatic individuals or"/>
 <result pre="asymptomatic individuals or their relative infectivity. Fig 3 Effect of" exact="infection" post="rate on epidemic threshold. The contours indicate the points"/>
 <result pre="between 2 and 4.25 [29–31], typically falling below 1 when" exact="complete" post="lockdowns are imposed [28]. The R0 values found here"/>
 <result pre="in all four states, indicating that the spread of the" exact="infection" post="is largely driven by asymptomatic individuals, at least in"/>
 <result pre="estimated in China [9] and might be indicative of the" exact="limited" post="testing availability in the United States early in the"/>
 <result pre="the United States early in the pandemic. The undercounting of" exact="symptomatic" post="infections is particularly problematic since each symptomatic person incorrectly"/>
 <result pre="United States early in the pandemic. The undercounting of symptomatic" exact="infections" post="is particularly problematic since each symptomatic person incorrectly classified"/>
 <result pre="The undercounting of symptomatic infections is particularly problematic since each" exact="symptomatic" post="person incorrectly classified as asymptomatic because they weren’t tested"/>
 <result pre="pre-symptomatic phase in this model; recent studies have shown that" exact="symptomatic" post="people can infect others during the pre-symptomatic phase [32–34]"/>
 <result pre="Fig 5 shows the time course of asymptomatic individuals and" exact="symptomatic" post="individuals for epidemics in all four states. In all"/>
 <result pre="of the epidemic, there are far more asymptomatic individuals than" exact="symptomatic" post="individuals. This is due not only to the high"/>
 <result pre="This is due not only to the high proportion of" exact="infections" post="that are asymptomatic, but is also caused by a"/>
 <result pre="asymptomatic, but is also caused by a faster removal of" exact="symptomatic" post="individuals as compared to asymptomatic individuals. While it might"/>
 <result pre="might seem unusual that asymptomatic individuals are recovering slower than" exact="symptomatic" post="individuals, given the heightened awareness of transmission of infectious"/>
 <result pre="than symptomatic individuals, given the heightened awareness of transmission of" exact="infectious diseases" post="as well as the stay-at-home orders in these states,"/>
 <result pre="diseases as well as the stay-at-home orders in these states," exact="symptomatic" post="individuals are likely to isolate themselves upon symptom onset,"/>
 <result pre="not true recovery, from the standpoint of the model, these" exact="symptomatic" post="people are classified as recovered. Therefore, asymptomatic individuals participate"/>
 <result pre="classified as recovered. Therefore, asymptomatic individuals participate in transmitting the" exact="infection" post="for a longer period of time and in greater"/>
 <result pre="individuals. It is also notable that the peak in asymptomatic" exact="infections" post="occurs slightly after the peak in symptomatic infections. This"/>
 <result pre="peak in asymptomatic infections occurs slightly after the peak in" exact="symptomatic" post="infections. This could have repercussions for decisions on when"/>
 <result pre="social distancing measures since we will observe a decline in" exact="infections" post="while asymptomatic infections are still increasing. Fig 5 Estimated"/>
 <result pre="since we will observe a decline in infections while asymptomatic" exact="infections" post="are still increasing. Fig 5 Estimated asymptomatic dynamics during"/>
 <result pre="the time at which the initial infected individual initiated the" exact="infection" post="in each state. Using our estimates of Td, we"/>
 <result pre="as early as January 15, while for Florida the estimated" exact="infection" post="start date is January 14. New York has the"/>
 <result pre="the latest is in Texas on January 24. Changing the" exact="infection" post="rate Strict stay-at-home measures have severe economic implications and"/>
 <result pre="fact that the asymptomatic peak is slightly later than the" exact="symptomatic" post="peak, we decided to investigate model predictions of what"/>
 <result pre="previous modeling study, we assume that stay-at-home orders cut the" exact="infection" post="rate β in half [9], so double the infection"/>
 <result pre="the infection rate β in half [9], so double the" exact="infection" post="rate at two week intervals starting on the last"/>
 <result pre="We see that there is an immediate spike in both" exact="symptomatic" post="and asymptomatic infections upon reopening and that the spike"/>
 <result pre="there is an immediate spike in both symptomatic and asymptomatic" exact="infections" post="upon reopening and that the spike becomes smaller as"/>
 <result pre="different times, we found the final death toll and the" exact="total" post="size of the epidemic for each reopening scenario. Results"/>
 <result pre="illness and deaths. For California, Florida, and Texas, both the" exact="total" post="epidemic size and the number of fatalities increase with"/>
 <result pre="2020). Discussion We analyzed a compartmental model that includes asymptomatic" exact="infections" post="finding that the relative infectiousness of asymptomatic individuals plays"/>
 <result pre="and size of the epidemic while the proportion of asymptomatic" exact="infections" post="plays a larger role in determining mortality. Yet testing"/>
 <result pre="role in determining mortality. Yet testing in many countries is" exact="limited" post="to people who are symptomatic, meaning that there is"/>
 <result pre="developed, previous studies have shown that the number of asymptomatic" exact="infections" post="also alters the effectiveness of vaccination strategies [20, 21]."/>
 <result pre="we found that there were far more asymptomatic individuals than" exact="symptomatic" post="individuals at the peak of the epidemic in all"/>
 <result pre="individuals can rise to high numbers. If the proportion of" exact="infections" post="that become asymptomatic is high (p close to 1),"/>
 <result pre="high (p close to 1), then as the number of" exact="infections" post="rise, more of these will be asymptomatic. It is"/>
 <result pre="also possible to accumulate large numbers of asymptomatic individuals if" exact="symptomatic" post="infections are removed from the epidemic, either through death,"/>
 <result pre="possible to accumulate large numbers of asymptomatic individuals if symptomatic" exact="infections" post="are removed from the epidemic, either through death, recovery,"/>
 <result pre="faster than asymptomatic infections. This might be the case if" exact="symptomatic" post="individuals are quickly tested and then isolated thereby being"/>
 <result pre="then isolated thereby being removed from further participation in the" exact="infection" post="as might be the case for these four states"/>
 <result pre="these states at the time this data was taken, was" exact="limited" post="to symptomatic individuals. This also points to a limitation"/>
 <result pre="at the time this data was taken, was limited to" exact="symptomatic" post="individuals. This also points to a limitation of this"/>
 <result pre="the number of asymptomatic cases and likely an undercount of" exact="symptomatic" post="cases. Thus the asymptomatic compartment in this application of"/>
 <result pre="the asymptomatic compartment in this application of the model includes" exact="symptomatic" post="patients who were unable to get tested. Our model"/>
 <result pre="pre-symptomatic phase, which also lumps people who likely have different" exact="infection" post="rates into one compartment. This mixing of individuals who"/>
 <result pre="in separate compartments as well as the inadequate counting of" exact="symptomatic" post="infections leads to error in our parameter estimates and"/>
 <result pre="separate compartments as well as the inadequate counting of symptomatic" exact="infections" post="leads to error in our parameter estimates and an"/>
 <result pre="four data sets used. Adequate testing protocols that capture both" exact="symptomatic" post="and asymptomatic infections will allow better parameterization of the"/>
 <result pre="used. Adequate testing protocols that capture both symptomatic and asymptomatic" exact="infections" post="will allow better parameterization of the model. Additional data,"/>
 <result pre="number of recovered, this number is really only reflective of" exact="symptomatic" post="patients who have been hospitalized and released. Symptomatic patients"/>
 <result pre="around 2 for all four states. This is at the" exact="lower" post="end of SARS-CoV R0 estimates in the absence of"/>
 <result pre="at the lower end of SARS-CoV R0 estimates in the" exact="absence of" post="any behavioral changes [29–31]. These low values of R0"/>
 <result pre="to 2.5, contact tracing only needs to capture 70% of" exact="infections" post="to be effective. Conclusion While the epidemiological model used"/>
 <result pre="key aspect of SARS-CoV-2 transmission. Our model shows that asymptomatic" exact="infections" post="can change the size and lethality of an epidemic"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. 10.1016/S0140-6736(20)30211-732007143"/>
 <result pre="ChenYM, WangW, SongZG, et al.A new coronavirus associated with human" exact="respiratory" post="disease in China. Nature. 2020;579(7798):265–271. 10.1038/s41586-020-2008-332015508 3GoyalP, ChoiJJ, PinheiroLC,"/>
 <result pre="WangW, SongZG, et al.A new coronavirus associated with human respiratory" exact="disease" post="in China. Nature. 2020;579(7798):265–271. 10.1038/s41586-020-2008-332015508 3GoyalP, ChoiJJ, PinheiroLC, SchenckEJ,"/>
 <result pre="CaiY, CheungCW, XiaZ. Review of the Clinical Characteristics of Coronavirus" exact="Disease" post="2019 (COVID-19). J Gen Intern Med. 2020;35:1545–1549. 10.1007/s11606-020-05762-w32133578 5GhinaiI,"/>
 <result pre="KirkingHL, ChristiansenD, JoshiK, et al.First known person-to-person transmission of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet."/>
 <result pre="ChristiansenD, JoshiK, et al.First known person-to-person transmission of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020;395(10230):1137–1144."/>
 <result pre="JoshiK, et al.First known person-to-person transmission of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020;395(10230):1137–1144. 10.1016/S0140-6736(20)30607-332178768"/>
 <result pre="2020;395(10230):1137–1144. 10.1016/S0140-6736(20)30607-332178768 6ChanJFW, YuanS, KokKH, ToKKW, ChuH, YangJ, et al.A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="YuanS, KokKH, ToKKW, ChuH, YangJ, et al.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
 <result pre="10.1111/irv.12743 9LiR, PeiS, ChenB, SongY, ZhangT, YangW, et al.Substantial undocumented" exact="infection" post="facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science."/>
 <result pre="10MizumotoK, KagayaK, ZarebskiA, ChowellG. Estimating the asymptomatic proportion of coronavirus" exact="disease" post="2019 (COVID-19) cases on board the Diamond Princess cruise"/>
 <result pre="KinoshitaR, et al.Estimation of the asymptomatic ratio of novel coronavirus" exact="infections" post="(COVID-19). Int J Inf Dis. 2020;94:154–155. 10.1016/j.ijid.2020.03.02032179137 12HoehlS, RabenauH,"/>
 <result pre="12HoehlS, RabenauH, BergerA, KortenbuschM, CinatlJ, BojkovaD, et al.Evidence of SARS-CoV-2" exact="Infection" post="in Returning Travelers from Wuhan, China. N Engl J"/>
 <result pre="HatfieldKM, AronsM, JamesA, TaylorJ, SpicerK, et al.Asymptomatic and Presymptomatic SARS-CoV-2" exact="Infections" post="in Residents of a Long-Term Care Skilled Nursing Facility—King"/>
 <result pre="15TianS, HuN, LouJ, ChenK, KangX, XiangZ, et al.Characteristics of COVID-19" exact="infection" post="in Beijing. J Infect. 2020;80(4):401–406. 10.1016/j.jinf.2020.02.01832112886 16ZhangJ, TianS, LouJ,"/>
 <result pre="in Beijing. J Infect. 2020;80(4):401–406. 10.1016/j.jinf.2020.02.01832112886 16ZhangJ, TianS, LouJ, ChenY." exact="Familial" post="cluster of COVID-19 infection from an asymptomatic. Crit Care."/>
 <result pre="2020;80(4):401–406. 10.1016/j.jinf.2020.02.01832112886 16ZhangJ, TianS, LouJ, ChenY. Familial cluster of COVID-19" exact="infection" post="from an asymptomatic. Crit Care. 2020;24(1):11910.1186/s13054-020-2817-732220236 17HuZ, SongC, XuC,"/>
 <result pre="Yaling ChenGJ, XuX, MaH, et al.Clinical characteristics of 24 asymptomatic" exact="infections" post="with COVID-19 screened among close contacts in Nanjing, China."/>
 <result pre="18RotheC, SchunkM, SothmannP, BretzelG, FroeschlG, WallrauchC, et al.Transmission of 2019-nCoV" exact="Infection" post="from an Asymptomatic Contact in Germany. N Engl J"/>
 <result pre="CampbellPT, WuY, TongSYC, McVernonJ, GeardN. Implications of asymptomatic carriers for" exact="infectious disease" post="transmission and control. Royal Soc Open Sci. 2018;5(2):17234110.1098/rsos.172341 20WangJ,"/>
 <result pre="WuY, TongSYC, McVernonJ, GeardN. Implications of asymptomatic carriers for infectious" exact="disease" post="transmission and control. Royal Soc Open Sci. 2018;5(2):17234110.1098/rsos.172341 20WangJ,"/>
 <result pre="20WangJ, WuD, SunH. Analysis of an SVIC model with age-dependent" exact="infection" post="and asymptomatic carriers. Appl Anal. 2018;97(9):1467–1495. 10.1080/00036811.2017.1313409 21ManyombeMLM, MbangJ,"/>
 <result pre="MbangJ, LubumaJ, TsanouB. Global dynamics of a vaccination model for" exact="infectious diseases" post="with asymptomatic carriers. Math Biosci Eng. 2016;13(4):813–840. 10.3934/mbe.201601927775386 22KucharskiAJ,"/>
 <result pre="Dis. 2016;10(5):e0004726. 23FraserC, RileyS, AndersonRM, NeilMF. Factors that make an" exact="infectious disease" post="outbreak controllable. Proc Natl Acad Sci USA. 2004;101(16):6146–6151. 10.1073/pnas.030750610115071187"/>
 <result pre="2016;10(5):e0004726. 23FraserC, RileyS, AndersonRM, NeilMF. Factors that make an infectious" exact="disease" post="outbreak controllable. Proc Natl Acad Sci USA. 2004;101(16):6146–6151. 10.1073/pnas.030750610115071187"/>
 <result pre="USA. 2004;101(16):6146–6151. 10.1073/pnas.030750610115071187 24LeungKY, TrapmanP, BrittonT. Who is the infector?" exact="Epidemic" post="models with symptomatic and asymptomatic cases. Math Biosci. 2018;301:190–198."/>
 <result pre="24LeungKY, TrapmanP, BrittonT. Who is the infector? Epidemic models with" exact="symptomatic" post="and asymptomatic cases. Math Biosci. 2018;301:190–198. 10.1016/j.mbs.2018.04.00229654792 25DeanNE, HalloranME,"/>
 <result pre="of Ebola Virus: A Systematic Review and Meta-analysis of Household" exact="Secondary" post="Attack Rate and Asymptomatic Infection. Clin Infect Dis. 2016;62(10):1277–1286."/>
 <result pre="Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary" exact="Attack" post="Rate and Asymptomatic Infection. Clin Infect Dis. 2016;62(10):1277–1286. 10.1093/cid/ciw11426932131"/>
 <result pre="Biological Model for Influenza Transmission: Pandemic Planning Implications of Asymptomatic" exact="Infection" post="and Immunity. Plos One. 2007;2(11):e122010.1371/journal.pone.000122018043733 27DengY, LiuW, LiuK, FangYY,"/>
 <result pre="et al.Clinical characteristics of fatal and recovered cases of coronavirus" exact="disease" post="2019 (COVID-19) in Wuhan, China: a retrospective study. Chin"/>
 <result pre="epidemiological and clinical features of the emerging 2019 novel coronavirus" exact="pneumonia" post="(COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568–576."/>
 <result pre="One. 2013;8(4):e6150410.1371/journal.pone.006150423585906 37BendavidE, MulaneyB, SoodN, ShahS, LingE, Bromley-DulfanoR, et al.COVID-19" exact="Antibody" post="Seroprevalence in Santa Clara County, California. medRxiv. 2020. 38SoodN,"/>
 <result pre="MCMC. Int J Biomath. 2013;6(7):135000810.1142/S1793524513500083 41ThompsonRN, GilliganCA, CunniffeNJ. Detecting Presymptomatic" exact="Infection" post="Is Necessary to Forecast Major Epidemics in the Earliest"/>
 <result pre="Necessary to Forecast Major Epidemics in the Earliest Stages of" exact="Infectious" post="Disease Outbreaks. PLoS Comput Biol. 2016;12(4):e100483610.1371/journal.pcbi.100483627046030 42RoosaK, ChowellG. Assessing"/>
 <result pre="to Forecast Major Epidemics in the Earliest Stages of Infectious" exact="Disease" post="Outbreaks. PLoS Comput Biol. 2016;12(4):e100483610.1371/journal.pcbi.100483627046030 42RoosaK, ChowellG. Assessing parameter"/>
 <result pre="in compartmental dynamic models using a computational approach: application to" exact="infectious disease" post="transmission models. Theor Biol Med Model. 2019;16:110.1186/s12976-018-0097-630642334 43HellewellJ, AbbottS,"/>
 <result pre="compartmental dynamic models using a computational approach: application to infectious" exact="disease" post="transmission models. Theor Biol Med Model. 2019;16:110.1186/s12976-018-0097-630642334 43HellewellJ, AbbottS,"/>
</results>
